AboutMorgan Health Investments

Investing in companies aligned to our mission of improving the quality, affordability and equity of employer-sponsored health care is a key pillar of our strategy. Our investments to date are focused on scaling innovations that meet the needs of employers and patients alike.

We make minority investments – directly from the JPMorganChase balance sheet – and typically seek late-stage ventures with demonstrable market fit and scale. Beyond our capital commitment, we offer strategic support to foster the long-term growth and development of our portfolio companies. This includes close engagement with Boards of Directors and executive leadership teams on strategy, product development, operational improvement, business development and strategic partnerships.

Morgan Health has a double bottom line – aiming to generate financial returns while also driving improvements in the U.S. health care system. Therefore, we are focused on accelerating solutions in the following areas:

Primary Care

Primary care is the cornerstone of the U.S. health care system, yet traditional models are hindered by misaligned incentives and patient engagement challenges. We invest in companies driving the adoption of advanced primary care solutions that elevate the quality of care and enhance employee satisfaction.

Specialist-Led Primary Care

Individuals with chronic illnesses or complex conditions often navigate fragmented care plans. We weigh investments that bolster access to comprehensive care coordination and meet the most pressing health care needs of distinct populations.

Small- and Medium-Sized Business (SMB) Solutions

Rising health care costs impose a significant burden on SMBs, with the smallest employers facing some of the steepest premium hikes. We explore investment opportunities that empower SMBs to provide affordable, high-quality, and equitable health care through new coverage models.

Data and Analytics

Employers need solutions that transform health care data into tailored and actionable insights. We consider investments that provide infrastructure and analytics capabilities that enhance administrative efficiency or drive improvements in health care quality and price transparency.

Pharmacy and Drug Management

Drug prices, particularly in categories like oncology, obesity, and cell and gene therapy, are outpacing inflation. We seek investment opportunities that address drug access and spending, with a specific focus on high-cost drugs or conditions prevalent in employer-sponsored insurance populations.